Get the Stockscreener App
0.7701
5.52%
-0.045
After Hours:
.76
-0.0101
-1.31%
Windtree Therapeutics Inc stock is traded at $0.7701, with a volume of 1.94M.
It is down -5.52% in the last 24 hours and up +71.32% over the past month.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
See More
Previous Close:
$0.8151
Open:
$0.7632
24h Volume:
1.94M
Relative Volume:
0.19
Market Cap:
$2.82M
Revenue:
-
Net Income/Loss:
$-11.38M
P/E Ratio:
-0.0278
EPS:
-27.73
Net Cash Flow:
$-12.72M
1W Performance:
-20.82%
1M Performance:
+71.32%
6M Performance:
+474.70%
1Y Performance:
-86.44%
1-Day Range:
$0.7632
$0.847
1-Week Range:
$0.75
$1.1999
52-Week Range:
$0.0915
$14.75
Windtree Therapeutics Inc Stock (WINT) Company Profile
Name
Windtree Therapeutics Inc
Sector
Industry
Phone
(215) 488-9300
Address
2600 KELLY ROAD, WARRINGTON, PA
Compare WINT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
0.7701 | 9.71M | 0 | -11.38M | -12.72M | -27.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-20 | Initiated | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc Stock (WINT) Latest News
Windtree Therapeutics Cuts Preferred Stock by Over 99% Ahead of Crypto Strategy Rollout - MSN
RSI Reset May Fuel Rebound in Windtree Therapeutics Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it
How Interest Rate Changes Impact Windtree Therapeutics Inc. Stock PerformanceChart-Based Trade Entries Gain Analyst Support - metal.it
Bitcoin News Today: Windtree Therapeutics Secures $520 Million to Expand BNB Treasury Strategy to $700 Million - AInvest
Why Windtree Therapeutics Inc. stock attracts strong analyst attentionWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - The Manila Times
Windtree Therapeutics Announces Significant Redemption and Conversion of Preferred Shares, BNB Coin Value Increases Following Crypto Treasury Agreement - Quiver Quantitative
Windtree Eliminates 99% of Preferred C Shares as BNB Crypto Strategy Sees 17% Gain - Stock Titan
What makes Windtree Therapeutics Inc. stock price move sharplyAlpha Focused Technical Trade Signals Gain Attention - metal.it
Windtree Therapeutics Inc. Sees Spike in Bullish Option FlowLow Capital High Return Stock Plans Reviewed - metal.it
Screener Results Flag Windtree Therapeutics Inc. as OversoldAI Driven Stock Trend Forecast Shows Momentum Shift - beatles.ru
Will Windtree Therapeutics Inc. stock benefit from AI tech trendsDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Is it the right time to buy Windtree Therapeutics Inc. stockBuild wealth with reliable stock picks - jammulinksnews.com
How does Windtree Therapeutics Inc. compare to its industry peersIdentify winners with top-tier analysis - jammulinksnews.com
What catalysts could drive Windtree Therapeutics Inc. stock higher in 2025Achieve breakthrough performance with smart picks - jammulinksnews.com
Should I hold or sell Windtree Therapeutics Inc. stock in 2025Consistently superior profits - jammulinksnews.com
How volatile is Windtree Therapeutics Inc. stock compared to the marketDaily Trading Outlook With Proven Results - jammulinksnews.com
What are analysts’ price targets for Windtree Therapeutics Inc. in the next 12 monthsFree Capital Allocation Plans - jammulinksnews.com
What is the dividend policy of Windtree Therapeutics Inc. stockBuild wealth faster with expert stock selection - jammulinksnews.com
Windtree Taps Kraken to Power BNB Crypto Treasury Strategy - MSN
What institutional investors are buying Windtree Therapeutics Inc. stockBuild a winning portfolio with smart picks - jammulinksnews.com
Sectors Driving Future Growth for Windtree Therapeutics Inc. StockSolid Return Trade Selections - metal.it
Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings - MSN
Windtree Therapeutics Secures $520M to Expand BNB Reserves in Strategic Pivot to Blockchain-Based Assets - AInvest
Windtree Therapeutics Allocates 99 of 520M Raise to BNB as Token Gains 175 Month-to-Date - AInvest
BNB Strategy: Windtree Therapeutics Targets New $520 Million Fund To Boost Holdings - TradingView
Windtree Therapeutics Forms Strategic Partnership with Kraken to Enhance Crypto Strategy. - AInvest
BNB Rebounds to $780 After $520M Windtree Buy Commitment, Shows Signs of Stabilizing - Yahoo Finance
Windtree Therapeutics Allocates $700M to Buy BNB After Token Hits All-Time High Stock Dips 5% - AInvest
News Explorer — This Nasdaq-Listed Drug Company Is Set to Buy $700 Million in BNB - Decrypt
Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High - Decrypt
Windtree Therapeutics Plans $520 Million Raise, 99% for BNB, Secures $500M Equity Line, Uses Kraken Custody - The Defiant
Windtree Therapeutics to establish equity line of credit - Pennsylvania Business Report -
Windtree Therapeutics Secures $520M to Boost BNB Holdings Stock Surges 537 5% in Six Months - AInvest
Windtree Therapeutics Allocates $520M to BNB 99% as First Nasdaq Firm with Direct Altcoin Exposure - AInvest
What analysts say about Windtree Therapeutics Inc. stockExceptional market performance - PrintWeekIndia
Windtree Therapeutics Allocates $520M to BNB via $500M ELOC and $20M Stock Deal - AInvest
Windtree Therapeutics Commits $520M to BNB in Bold Treasury Pivot - AInvest
Nasdaq-listed Windtree Therapeutics Commits $520M to BNB in Bold Treasury Pivot - Blockonomi
Windtree Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - PrintWeekIndia
Is Windtree Therapeutics Inc. a good long term investmentRobust financial gains - PrintWeekIndia
Windtree Therapeutics Boosts Market Position with Strategic Partnerships and Innovations - StocksToTrade
Windtree Therapeutics stock rises after securing $500M equity line for BNB strategy - Investing.com
Windtree Therapeutics (WINT) Secures $520M for BNB Cryptocurrenc - GuruFocus
Windtree Therapeutics Secures $500M Equity Line for Crypto - TipRanks
Windtree Therapeutics commits up to $700 million for BNB purchases - Investing.com
Windtree Therapeutics Inc Stock (WINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):